Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2014
05/01/2014WO2014037800A3 Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
05/01/2014WO2014023285A3 Transgenic plant of the species solanum tuberosum with resistance to phytophthora
05/01/2014WO2014022702A3 Methods and compositions for controlling gene expression by rna processing
05/01/2014WO2014008263A3 Paramyxovirus and methods of use
05/01/2014WO2014004572A3 Modulation of ube3a-ats expression
05/01/2014WO2014004124A3 Method for amplification gene fusion complexes
05/01/2014WO2013120726A3 A skin lightening composition
05/01/2014WO2013009979A3 Compositions and methods for suppressing gene expression of p53 and clusterin
05/01/2014WO2012177619A3 Microorganisms for producing 1,3-butanediol and methods related thereto
05/01/2014WO2012154759A3 Genetically engineered growth factor variants
05/01/2014WO2012145729A3 Methods and compositions for modulating gene expression using components that self assemble in cells and produce rnai activity
05/01/2014WO2012138731A3 Activated nucleoside analog conjugates and methods of use thereof
05/01/2014WO2012135820A3 Edible transgenic plants as oral delivery vehicles for rna-based therapeutics
05/01/2014WO2012135591A3 Microbial isoprenoid production using a heterologous dxp pathway
05/01/2014WO2012135246A3 Compositions and methods for inhibiting expression of tmprss6 gene
05/01/2014WO2012122412A3 Compositions for reducing risk of adverse events caused by drug-drug interactions
05/01/2014US20140123345 Truncated glyceraldehyde-3-phosphate dehydrogenase promoter
05/01/2014US20140123344 Plants Having Enhanced Yield-Related Traits and Method for Making the Same
05/01/2014US20140123343 Plants Having Enhanced Yield-Related Traits and Method for Making the Same
05/01/2014US20140123342 Regulation of Stomatal Apertures by Apyrases and Extracellular Nucleotides
05/01/2014US20140123341 Method for the transient expression of nucleic acids in plants
05/01/2014US20140123340 Plants Having Increased Tolerance to Herbicides
05/01/2014US20140123339 Transformed Plants Having Increased Beta-Carotene Levels, Increased Half-Life and Bioavailability and Methods of Producing Such
05/01/2014US20140123338 Nucleotide sequences mediating male fertility and method of using same
05/01/2014US20140123337 Lettuce variety 45-114 rz
05/01/2014US20140123335 Lettuce variety 41-108 rz
05/01/2014US20140123334 Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants
05/01/2014US20140123331 Trait improvement in plants expressing ap2 proteins ii
05/01/2014US20140123330 Control of sexual maturation in animals
05/01/2014US20140121365 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
05/01/2014US20140121364 Oligomeric compounds and compositions for use in modulation of small non-coding rnas
05/01/2014US20140121264 MICRORNA (miRNA) AND DOWNSTREAM TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
05/01/2014US20140121263 Lipid formulated dsrna targeting the pcsk9 gene
05/01/2014US20140121262 Methods of Using microRNA-26a to Promote Angiogenesis
05/01/2014US20140121261 C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders
05/01/2014US20140121167 Therapeutic peptides and use thereof against huntington's disease
05/01/2014US20140121131 Method of protein display
05/01/2014US20140121123 Methods for diversifying antibodies, antibodies derived therefrom and uses thereof
05/01/2014US20140121118 Methods, systems and compositions regarding multiplex construction protein amino-acid substitutions and identification of sequence-activity relationships, to provide gene replacement such as with tagged mutant genes, such as via efficient homologous recombination
05/01/2014US20140121115 Custom-made meganuclease and use thereof
05/01/2014US20140120625 Simultaneous Site-Specific Integrations of Multiple Gene-Copies in Filamentous Fungi
05/01/2014US20140120624 Cassettes and methods for transforming and selecting yeast transformants by homologous recombination
05/01/2014US20140120623 Method for Enhancing Cell Growth of Microalgae
05/01/2014US20140120622 T cell modifying compounds and uses thereof
05/01/2014US20140120612 Engineered cleavage half-domains
05/01/2014US20140120611 Method for the production of fucosyllactose in bacterial cells
05/01/2014US20140120592 Recombinant caldicellulosiruptor bescii and methods of use
05/01/2014US20140120585 Nucleic acid extraction device, and nucleic acid extraction method, nucleic acid extraction kit, and nucleic acid extraction apparatus, each using the same
05/01/2014US20140120580 System for antibody expression and assembly
05/01/2014US20140120578 Plants for production of therapeutic proteins
05/01/2014US20140120577 Metalloporphyrin Inducible Promoter
05/01/2014US20140120576 Nucleic acid which is stabilized against decomposition
05/01/2014US20140120569 Sebocytes, sebocyte cell lines and applications thereof
05/01/2014US20140120553 T2r, a novel family of taste receptors
05/01/2014US20140120544 Method and materials for isolation of nucleic acid materials
05/01/2014US20140120237 New melon variety nun 0030 me
05/01/2014US20140120136 Mir-155 enhancement of cd8+ t cell immunity
05/01/2014US20140120134 Live, oral vaccine for protection against shigella dysenteriae serotype 1
05/01/2014US20140120132 Lentiviral vectors containing an mhc class i promoter
05/01/2014US20140120107 Genes of an otitis media isolate of nontypeable haemophilus influenzae
05/01/2014US20140120098 Fibcd1 for the prevention and treatment of diseases
05/01/2014US20140120089 Antibodies to insulin-like growth factor i receptor
05/01/2014US20140120085 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
04/2014
04/30/2014EP2725125A1 High throughput methylation detection method
04/30/2014EP2725103A2 Methods and compositions for treating prostate cancer
04/30/2014EP2725102A1 Nucleic acid extraction device, and nucleic acid extraction method, nucleic acid extraction kit, and nucleic acid extraction apparatus, each using the same
04/30/2014EP2725101A1 Protein comprising truncated form of extracellular domain protein of frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein
04/30/2014EP2723897A2 Multivariate diagnostic assays and methods for using same
04/30/2014EP2723896A2 Mutations in pancreatic neoplasms
04/30/2014EP2723895A2 Molecular diagnostic panel of eosinophilic gastrointestinal disorders
04/30/2014EP2723874A2 Methods and compositions for producing male sterile plants
04/30/2014EP2723873A1 P0 gene silencing constructs and use
04/30/2014EP2723872A1 Genetically enhanced cyanobacteria lacking functional genes conferring biocide resistance for the production of chemical compounds
04/30/2014EP2723871A1 Enhanced heterologous protein production in kluyveromyces marxianus
04/30/2014EP2723870A1 Modified microorganisms and use thereof for terpene production
04/30/2014EP2723869A1 An il-15 and il-15r sushi domain based immunocytokines
04/30/2014EP2723868A1 Process for preparing genetically transformed yeasts capable of producing a molecule of interest at a high titre
04/30/2014EP2723867A1 Phacosporacea resistant soybean plants
04/30/2014EP2723866A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
04/30/2014EP2723865A1 Assays and methods for determining activity of a therapeutic agent in a subject
04/30/2014EP2723864A2 Phenocopy model of disease
04/30/2014EP2723863A1 Hcv combination therapy
04/30/2014EP2723862A1 Albumin production and cell proliferation
04/30/2014EP2723861A2 Compositions and methods for inhibiting hepcidin antimicrobial peptide (hamp) or hamp-related gene expression
04/30/2014EP2723860A1 Method of metabolic evolution
04/30/2014EP2723859A1 Microfluidic photoporation
04/30/2014EP2723855A2 Influenza virus mutants and uses therefor
04/30/2014EP2723756A2 Compositions and methods for inhibition of expression of apolipoprotein c-iii (apoc3) genes
04/30/2014EP2723450A2 Combination therapy
04/30/2014EP2723371A1 Hpv vaccine formulations comprising aluminum adjuvant and methods of producing same
04/30/2014EP2723349A2 Microrna-31 compositions and methods for use in autoimmune disease
04/30/2014EP2723162A2 Plants having enhanced yield-related traits and a method for making the same
04/30/2014EP2723160A1 Means and methods for the determination of prediction models associated with a phenotype
04/30/2014CN103764850A Method for detecting toxin-producing clostridium difficile
04/30/2014CN103764831A Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
04/30/2014CN103764830A Composition comprising inhibitors of IRS-1 and of VEGF
04/30/2014CN103764829A Methods, compositions, and kits for determining hepatitis a virus
04/30/2014CN103764828A Method of metabolic evolution
04/30/2014CN103764827A Reagent usable for the isolation and/or purification of nucleic acids
04/30/2014CN103764826A Receptor gene for peptide cancer antigen-specific t cell
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 4023